Asthma
Discover curated resources and information to support further understanding of asthma.
*Image is not an actual patient.
Asthma overview
Addressing the challenge of asthma
Asthma, a chronic lung condition affecting around 2.8 million Australians (11% of the population)¹, poses significant health challenges and reduces quality of life for many. Effective management of moderate to severe asthma is essential to improve patient outcomes and healthcare efficiency.
Don’t miss these key links
For healthcare professionals, staying informed about asthma and evolving patient needs is crucial for providing the best possible care. The international scientific community is actively investigating several broad areas within asthma research:

- Inflammation and immunology: Research aims to understand and target underlying inflammatory pathways
- Airway remodeling: Efforts focus on preventing and reversing structural changes in the airways
- Personalized medicine: The goal is to develop targeted therapies for severe asthma phenotypes
- Comorbidities: Work centers on managing co-occurring conditions that impact asthma control
- Patient engagement: Initiatives address improving adherence and self-management strategies for optimal outcomes

Register as a healthcare professional today to gain full access to the latest asthma research, curated resources, and education.
Facts about asthma in Australia
For healthcare professionals in Australia, having a clear picture of the disease's impact is essential to provide effective, compassionate care.
Prevalence: Asthma affects around 2.8 million Australians, representing 10.8% of the population in 2022.*
Management gap: Only 32% of Australians with asthma have a written asthma action plan in place.†
Patient impact: Up to 90% of asthma patients fail to use their inhaler correctly, impacting treatment efficacy.‡
*Australian Bureau of Statistics. Asthma [Internet]. Canberra: ABS; 2023 Dec 15 [cited 2025 May 23]. Available from: https://www.abs.gov.au/statistics/health/health-conditions-and-risks/asthma/latest-release
†National Asthma Council Australia. Asthma facts and statistics [Internet]. Melbourne VIC: National Asthma Council Australia; [cited 2025 May 23]. Available from: https://www.nationalasthma.org.au/asthma-facts-and-statistics
‡Lung Foundation Australia. Using Your Inhaler [Internet]. Brisbane QLD: Lung Foundation Australia; 2025 November 25 [cited 2025 Dec 3]. Available from: https://lungfoundation.com.au/support-and-resources/living-with-a-lung-disease/using-your-inhaler/​
Featured content
The clinical evolution of COPD: Watch expert insights
Gain the latest clinical insights on COPD in five expert-led videos
Explore the pathophysiology and management of COPD with International Expert Prof. Nicola Hanania (USA) and Respiratory Physician Prof. Philip Bardin (Australia).
Register to receive full access
Register in less than a minute to access the latest updates and resources to support your practice and help deliver better outcomes for your patients.
Science and education
Evolving asthma landscape: watch expert perspectives
Gain global clinical insights in four short expert-led videos
Severe asthma in 2024 – Insights from Professor Liam Heaney
International expert Prof. Liam Heaney shares his insights into severe asthma management
Respiratory 2023: Remission or 'super responders' in severe asthma
Event two: Remission or 'super responders' in severe asthma: same or different?
Recorded on: 10 August 2023
ADVENT Respiratory 2023: Biomarkers
Event one: Biomarkers to manage severe asthma in clinical practice
Recorded on: 9 March 2023
3 practical ways to harness FeNO for severe asthma management
International expert Prof. Liam Heaney shares his experience
Can’t find what you’re looking for?
Search our extensive Content Library
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention [Internet]. 2024 [cited 2025 Jun 5]. Available from: https://ginasthma.org/gina-reports/
MAT-AU-2301928 - 4.0 - 11/2025
Waddling-Gait---Robert,-28-year-old-mild-LOPD-patient
Waddling Gait - Robert, 28-year-old mild LOPD patient
Reaching-Overhead---Robert,-28-year-old-mild-LOPD-patient
Reaching Overhead - Robert, 28-year-old mild LOPD patient
Standing-From-Sitting---Robert,-28-year-old-mild-LOPD-patient
Standing From Sitting - Robert, 28-year-old mild LOPD patient
Climbing-Stairs---Robert,-28-year-old-mild-LOPD-patient
Climbing Stairs - Robert, 28-year-old mild LOPD patient
Waddling-Gait---Karen,-18-year-old-moderate-LOPD-patient
Waddling Gait - Karen, 18-year-old moderate LOPD patient
Reaching-Overhead---Karen,-18-year-old-moderate-LOPD-patient
Reaching Overhead - Karen, 18-year-old moderate LOPD patient
Standing-From-Sitting---Karen,-18-year-old-moderate-LOPD-patient
Standing From Sitting - Karen, 18-year-old moderate LOPD patient
Climbing-Stairs---Karen,-18-year-old-moderate-LOPD-patient
Climbing Stairs - Karen, 18-year-old moderate LOPD patient
ASPIRE-ICT-1-23_Harrington_MAT-AU-2302788-1
ASPIRE-ICT-1-23_Kyle-Blakey_MAT-AU-2302789-1
Which-biologic-and-why--When-to-switch-to-another-one-
Waddling-Gait---Brian,-44-year-old-severe-LOPD-patient
Waddling Gait - Brian, 44-year-old severe LOPD patient
Reaching-Overhead---Brian,-44-year-old-severe-LOPD-patient
Reaching Overhead - Brian, 44-year-old severe LOPD patient
Standing-From-Sitting---Brian,-44-year-old-severe-LOPD-patient
Standing From Sitting - Brian, 44-year-old severe LOPD patient
Climbing-Stairs---Brian,-44-year-old-severe-LOPD-patient
Climbing Stairs - Brian, 44-year-old severe LOPD patient
RESP-ICT2_Wark_MAT-AU-2301970
.webp/jcr:content/RESP-ICT2-Wark_400X300%20(1).webp)
RESP-ICT2_Wark_MAT-AU-2301970
RESP-ICT2_Stone_MAT-AU-2301972
.webp/jcr:content/RESP-ICT2-Stone_400X300%20(1).webp)
RESP-ICT2_Stone_MAT-AU-2301972
Remission-in-rheumatology---Dr-Michelle-Tellus
.webp/jcr:content/RESP-ICT2-Tellus_400X300%20(1).webp)
Remission in rheumatology - Dr Michelle Tellus
Pavord_MAT-AU-2300571
Pavord_MAT-AU-2300571
Wark_MAT-AU-2300572
Wark_MAT-AU-2300572
Q-A-Discussion_MAT-AU-2300573
Q&A-Discussion_MAT-AU-2300573
RESP-ICT3_Tellus_MAT-AU-2302033
RESP-ICT3_Tellus_MAT-AU-2302033
RESP-ICT3_Lee_MAT-AU-2302034
RESP-ICT3_Lee_MAT-AU-2302034
RESP-ICT3_Hew_MAT-AU-2302035
RESP-ICT3_Hew_MAT-AU-2302035
Reduced-need-for-sinus-surgery
Up-to-45--of-severe-asthma-patients-have-comorbid-CRSwNP
Severe-asthma-with-comorbid-CRSwNP-leads-to-more-severe-disease
.png)
Less-rescue-oral-corticosteriod-use
Improved-sense-of-smell
Reduced-obstruction-and-congestion
Reduced-asthma-exacerbations-and-improved-lung-function
IL-4-and-IL-13-are-key-and-central-drivers-of-type-2-inflammation
Gaucher-diagnosis-1
RESP-ICT2_Debate_MAT-AU-2301973
RESP-ICT2_Debate_MAT-AU-2301973
RESP-ICT3_Q-A_MAT-AU-2302036
RESP-ICT3_Q&A_MAT-AU-2302036
ASPIRE-ICT1-23_Q-A_MAT-AU-2302791-1
RESP-ICT2_Stone_CS_MAT-AU-2301975
RESP-ICT2_Stone_CS_MAT-AU-2301975
RESP-ICT2_Wark_CS_MAT-AU-2301974
RESP-ICT2_Wark_CS_MAT-AU-2301974
RESP-ICT2_Panel-Discussion_MAT-AU-2301976
RESP-ICT2_Panel-Discussion_MAT-AU-2301976
SANA7993_Safety-Page-Tables_V0.2_1_New3
Products_Dermatology_Atopic-Dermatitis_Adverse-Events-Adults_18012021
